Outcomes and Care of Patients With Acute Heart Failure Syndromes and Cardiac Troponin Elevation

Background—Cardiac troponins (cTn) may be elevated among patients with acute heart failure syndromes (AHFS). However, the optimal approach to management of AHFS with elevated cTn is unknown. Methods and Results—We compared the care and outcomes of 13 656 patients with AHFS seeking care in the emergency department stratified by presence (cTn+, n=1845, 13.5%) or absence (cTn−) of elevated troponin. Clinically abstracted data on patients who were admitted or discharged from the emergency department in Ontario, Canada (April 1999 to March 2001 and April 2004 to March 2007) were examined. In an exploratory 2:1 propensity-matched analysis, we examined whether early coronary revascularization (within 14 days of emergency department visit) was associated with survival, stratified by cTn status. For cTn+ AHFS, rates of coronary angiography (21.8 vs 11.4 patients/100 person-years; P<0.001) and coronary revascularization (8.8 vs 3.2 patients/100 person-years; P<0.001) were higher than cTn−. Instantaneous 30-day adjusted hazard ratios for cTn+ versus cTn− patients were 9.17 (95% confidence interval [CI], 8.31–10.12; P<0.001) for death, 5.14 (95% CI, 4.66–5.67; P<0.001) for cardiovascular readmission, and 13.08 (95% CI, 10.95–15.62; P<0.001) for ischemic heart disease hospitalization. In propensity-matched analysis of 143 individuals with cTn+ AHFS, early coronary revascularization was associated with reduced mortality (adjusted hazard ratio, 0.29; 95% CI, 0.09–0.92; P=0.036) compared with those who were not revascularized. Mortality was not significantly reduced among 210 cTn− patients undergoing early coronary revascularization (adjusted hazard ratio, 0.61; 95% CI, 0.36–1.03; P=0.065). Conclusions—Elevated cTn was associated with increased risk of death and cardiovascular hospitalizations. Highly selected cTn+ patients who underwent early coronary revascularization for obstructive coronary artery disease experienced improved survival.

[1]  O. Milo,et al.  Faculty Opinions recommendation of Prediction of heart failure mortality in emergent care: a cohort study. , 2012 .

[2]  Medicaid Services,et al.  International Classification of Diseases, Ninth Revision, Clinical Modification , 2011 .

[3]  P. Austin.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[4]  Christopher M O'Connor,et al.  Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. , 2010, Journal of the American College of Cardiology.

[5]  E. Adamopoulou,et al.  Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. , 2010, International journal of cardiology.

[6]  P. Austin,et al.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies , 2010, Pharmaceutical statistics.

[7]  A. Laupacis,et al.  Early Deaths in Patients With Heart Failure Discharged From the Emergency Department: A Population-Based Analysis , 2010, Circulation. Heart failure.

[8]  Peter C Austin,et al.  The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies , 2010, Statistics in medicine.

[9]  Peter C Austin,et al.  Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. , 2009, JAMA.

[10]  Daniel Levy,et al.  Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute , 2009, Circulation.

[11]  C. O'connor,et al.  Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2009, American heart journal.

[12]  M. Gheorghiade,et al.  Acute heart failure syndromes , 2009, Journal of the American College of Cardiology.

[13]  G. Fonarow,et al.  Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: A report from OPTIMIZE‐HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) * , 2008, European journal of heart failure.

[14]  Sharon-Lise T. Normand,et al.  An Administrative Claims Measure Suitable for Profiling Hospital Performance on the Basis of 30-Day All-Cause Readmission Rates Among Patients With Heart Failure , 2008, Circulation. Cardiovascular quality and outcomes.

[15]  Harlan M Krumholz,et al.  Statistical models and patient predictors of readmission for heart failure: a systematic review. , 2008, Archives of internal medicine.

[16]  G. Fonarow,et al.  Cardiac troponin and outcome in acute heart failure. , 2008, The New England journal of medicine.

[17]  C. Specchia,et al.  The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT‐proBNP and cardiac troponin‐T , 2007, European journal of heart failure.

[18]  C. Yancy,et al.  Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). , 2007, American heart journal.

[19]  A. Cohen-Solal,et al.  Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. , 2007, JAMA.

[20]  Peter C Austin,et al.  Relation between cardiac troponin I and mortality in acute decompensated heart failure. , 2007, American heart journal.

[21]  K. Swedberg,et al.  Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. , 2007, JAMA.

[22]  Peter C Austin,et al.  A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study , 2007, Statistics in medicine.

[23]  P. Ponikowski,et al.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. , 2006, European heart journal.

[24]  D. Levy,et al.  Association of parental heart failure with risk of heart failure in offspring. , 2006, The New England journal of medicine.

[25]  Harlan M Krumholz,et al.  An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With Heart Failure , 2006, Circulation.

[26]  V. Hasselblad,et al.  Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. , 2005, Journal of cardiac failure.

[27]  Eduardo R Perna,et al.  Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. , 2005, International journal of cardiology.

[28]  Peter C Austin,et al.  Comparison of Coding of Heart Failure and Comorbidities in Administrative and Clinical Data for Use in Outcomes Research , 2005, Medical care.

[29]  Christopher M O'Connor,et al.  Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. , 2003, Journal of the American College of Cardiology.

[30]  P. Poole‐Wilson,et al.  Coronary artery disease as the cause of incident heart failure in the population. , 2001, European heart journal.

[31]  P. Austin,et al.  Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[32]  Z. Ying,et al.  Checking the Cox model with cumulative sums of martingale-based residuals , 1993 .

[33]  S. Werns.  Effect of Nesiritide in Patients with Acute Decompensated Heart Failure , 2012 .

[34]  E. Rackow.  Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.

[35]  D. Juurlink,et al.  Enhancing the effectiveness of health care for Ontarians through research Canadian Institute for Health Information Discharge Abstract Database : A Validation Study , 2006 .

[36]  G. Braemer.  International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[37]  Brämer Gr.  International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[38]  S. Shaughnessy,et al.  Do No Harm: Health Systems’ Duty to Promote Clinician Well-Being , 2022, American Journal of Hospital Medicine.